DOCK2 and cancer: In this context, KCNAB2, H2AFY, DOCK2 and GSTM1 in our signature significant high expression in high‐risk group compare to low‐risk group and related to poor prognosis, and all genes except KCNAB2 in signature have been reported to be involved in cancer.